Skip to main content
AGEN logo

AGEN · Agenus Inc · Metrics

Track AGEN — free
$6.37 -0.36 (-5.35%) Q2 2025 earnings call transcript
Market Cap
$304.51M
Shares
45.25M
Volume · Nov 16 314.12K Avg daily vol (3M) 962.63K

AGEN metrics

96 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$6.73
Market cap
$304.51M

Price action

23 metrics
Price change (1W)
-5.9%
Price change (30D)
+11.4%
Price change (3M)
-8.1%
Price change (6M)
+88.0%
Price change (YTD)
+114.3%
Price change (1Y)
+55.4%
Trailing year
Price change (5Y)
—
52-week high
$9.93
52-week low
$2.77
Change from 52-week high
-32.2%
Change from 52-week low
+143.0%
Annualized volatility
120.7%
Annualized volatility (3M)
89.3%
Implied volatility (30D)
108.1%
IV rank (1Y)
27.5
IV percentile (1Y)
53.3
Beta
1.5
RSI (14D)
46.5
Price vs SMA 50
-8.7%
Price vs SMA 200
+31.7%
Avg volume (3M)
962,634
Relative volume
0.5
Average dollar volume
$7.37M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
45.25M

Valuation

12 metrics
P / E (TTM)
6.0
Trailing earnings · reciprocal yield 16.6%
PEG ratio
—
EV / revenue
1.8×
reciprocal yield 54.2%
EV / EBITDA
4.6×
reciprocal yield 22.0%
EV / EBIT
4.7×
reciprocal yield 21.1%
P / sales
2.3×
reciprocal yield 44.0%
P / book
—
FCF yield
-34.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
10.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
71.8×
reciprocal yield 1.4%
EV / revenue historical average (3Y)
1.3×
reciprocal yield 79.6%
EV / revenue historical average (5Y)
1.9×
reciprocal yield 53.4%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
10.7×
reciprocal yield 9.3%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
8.5×
reciprocal yield 11.8%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-05

Profitability

9 metrics
Gross margin
100.0%
Operating margin
38.9%
Trailing 12 months
Net margin
23.0%
Gross profit (TTM)
$133.95M
Operating profit (TTM)
$52.15M
Net income (TTM)
$30.75M
Trailing 12 months
Diluted EPS (TTM)
$1.12
FCF margin
-77.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$3.12
Gross profit per diluted share (TTM)
$3.12
Operating profit per diluted share (TTM)
$1.23
EBITDA per diluted share (TTM)
$1.29
Net income per diluted share (TTM)
$0.72
Operating cash flow per diluted share (TTM)
$-2.43
Free cash flow per diluted share (TTM)
$-2.43
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
$1.03
Stock compensation per diluted share (TTM)
$0.26
Book value per share
$-7.68

Growth

11 metrics
Revenue growth YoY
+4.1%
Year over year
Net income growth YoY
-95.7%
Revenue (TTM)
$133.95M
Trailing 12 months
EPS growth YoY
-99.0%
Shares change YoY
+153.4%
Year over year · more shares
Revenue CAGR (3Y)
+5.2%
Revenue CAGR (5Y)
+5.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
12.5%
Debt / equity
—
Current ratio
0.7
EBITDA (TTM)
$54.36M
Free cash flow (TTM)
−$103.86M
Quick ratio
—
Interest coverage
0.9
Net debt / EBITDA
-1.1
Return on invested capital
—
Trailing 12 months
Net cash
$57.15M
Latest balance sheet
Cash & equivalents
$66.94M
Total assets
$245.55M
Total debt
$29.78M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$103.86M
Capital expenditures (TTM)
$0
R&D (TTM)
$45.74M
SG&A (TTM)
—
Stock compensation (TTM)
$11.11M
R&D / revenue
34.1%
Stock compensation / revenue
8.3%

Ownership (13F)

9 metrics
13F filers
104
13F filer change QoQ
+16
Institutional ownership
31.5%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
6.9%
Private-fund adviser ownership
6.4%
Active holders' share change QoQ
+16.4%
Holder tenure
7.9
Price vs estimated holder cost
-16.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
8.5%

Short interest

3 metrics
Short interest
16.8%
Latest settlement · 10.7 days to cover
Days to cover
10.7d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1098972 CUSIP 00847G804 13F (30d) 94 filings 81 filers Visit website Investor relations